---
title: "Enzyme Replacement Therapy Medicines"
ocid: "ocds-r6ebe6-0000774980"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000774980"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000774980.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000774980.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"NSS\")"
published: "2024-08-15"
---

# Enzyme Replacement Therapy Medicines

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")  
Current stage: Award  
OCID: ocds-r6ebe6-0000774980

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000774980)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000774980.json)

## Summary

The Common Services Agency, more commonly known as NHS National Services Scotland (NSS), has completed a procurement process for the supply of Enzyme Replacement Therapy Medicines. The procurement falls under the Health industry category and is to be delivered to all entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014. The awarded contract, valued at £6,079,596, is under a limited procurement method without prior publication of a call for competition, owing to the exclusive rights of the medicines involved. The contract, which was signed on 19 July 2024, follows a streamlined process due to legal regulations protecting intellectual property rights.

This tender represents a significant opportunity for suppliers specialising in pharmaceutical products, particularly those with expertise in Enzyme Replacement Therapy Medicines. Businesses capable of meeting stringent regulatory requirements and those that hold exclusive rights to such specialised medicines are particularly well-suited to this type of procurement. The awarded contract, secured by Takeda UK Limited, showcases an environment where high-value contracts can drive significant business growth within the healthcare and pharmaceutical sectors, especially for companies that can align closely with the specific needs and legal frameworks governing such specialised goods.

## Notice

Supply of Enzyme Replacement Therapy Medicines (e-g) to NHS Scotland: - NP92624(e) Velaglucerase alfa 400units powder for solution for infusion vials 1 vial (VPRIV(r)) - NP92624(f) Idursulfase 6mg/3ml solution for infusion vials 1 vial (Elaprase(r)) - NP92624(g) Agalsidase alfa 3.5mg/3.5ml solution for infusion vials 1 vial (Replagal(r))

### Lot Information

Lot 1

The Framework Agreement is for the supply of Enzyme Replacement Therapy Medicines (e-g: VPRIV(r)/ Elaprase(r)/ Replagal(r)) to NHS Scotland. The Authority has awarded this framework as a Single supplier framework agreement to one (1) Framework Participant.

### Procurement Information

The medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG512134 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 15 Aug 2024 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 19 Jul 2024 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £6,079,596 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | TAKEDA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 15 Aug 2024 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG512134

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG512134
  Enzyme Replacement Therapy Medicines - Supply of Enzyme Replacement Therapy Medicines (e-g) to NHS Scotland: - NP92624(e) Velaglucerase alfa 400units powder for solution for infusion vials 1 vial (VPRIV(r)) - NP92624(f) Idursulfase 6mg/3ml solution for infusion vials 1 vial (Elaprase(r)) - NP92624(g) Agalsidase alfa 3.5mg/3.5ml solution for infusion vials 1 vial (Replagal(r))

## Notice URLs

- http://
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000774980

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000774980. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000774980.json.